Off-label use of recombinant activated factor VII increases risk of arterial events
Off-label use of recombinant activated factor VII (rFVIIa) increases the risk of arterial but not venous thromboembolic events, particularly in…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.